Cite
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
MLA
Woodworth, Kate R., et al. “The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.” MMWR: Morbidity & Mortality Weekly Report, vol. 70, no. 45, Nov. 2021, pp. 1579–83. EBSCOhost, https://doi.org/10.15585/mmwr.mm7045e1.
APA
Woodworth, K. R., Moulia, D., Collins, J. P., Hadler, S. C., Jones, J. M., Reddy, S. C., Chamberland, M., Campos-Outcalt, D., Morgan, R. L., Brooks, O., Talbot, H. K., Lee, G. M., Bell, B. P., Daley, M. F., Mbaeyi, S., Dooling, K., & Oliver, S. E. (2021). The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021. MMWR: Morbidity & Mortality Weekly Report, 70(45), 1579–1583. https://doi.org/10.15585/mmwr.mm7045e1
Chicago
Woodworth, Kate R., Danielle Moulia, Jennifer P. Collins, Stephen C. Hadler, Jefferson M. Jones, Sujan C. Reddy, Mary Chamberland, et al. 2021. “The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.” MMWR: Morbidity & Mortality Weekly Report 70 (45): 1579–83. doi:10.15585/mmwr.mm7045e1.